Physician profile
Timothy Gelety
NPI 1376656694
$751.26
in general payments reported to CMS, 2019-2025
10 companies · $61.37 in 2025
The $61.37 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $116 · 2021: $134 · 2022: $71.04 · 2023: $49.86 · 2024: $57.44 · 2025: $61.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128 · Debt Forgiveness: $40.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.14 |
| Debt Forgiveness | $40.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $377.42 | 2019-2022 | |
| Myovant Sciences INC. | $117.06 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $69.36 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $60.18 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System |
| Vitrolife INC. | $40.53 | 2024 | |
| Galen US INC | $25.68 | 2019 | |
| Baxter Healthcare | $16.91 | 2024 | Tisseel |
| Caldera Medical, INC | $16.08 | 2021 | |
| Emd Serono, INC. | $14.94 | 2021 | |
| Therapeuticsmd, INC. | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Gelety listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.